Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Holtzman

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Annals of Surgical Oncology|October 11, 2018
Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal MalignanciesM Haroon A Choudry, Yongli Shuai, Heather L Jones, et al.
The Journal of Surgical Research|January 5, 2025
Patient Perspectives of Fertility Following Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: An Opportunity for Improved Perioperative CounselingCameron Schlegel, Amy R Copeland, Michelle Liebdzinski, et al.
Annals of Surgical Oncology|March 3, 2019
Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal MetastasesHaroon A Choudry, Filip Bednar, Yongli Shuai, et al.
Annals of Surgery|October 31, 2013
Outcome analysis of a decade-long experience of isolated hepatic perfusion for unresectable liver metastases at a single institutionDeepa Magge, Haroon A Choudry, Herbert J Zeh, et al.
Journal of Surgical Oncology|January 19, 2016
Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapyTimothy D Lyon, Robert M Turner Ii, Tara N Nikonow, et al.
Journal of Surgical Oncology|February 7, 2013
Aggressive locoregional management of recurrent peritoneal sarcomatosisJoel M Baumgartner, Steven A Ahrendt, James F Pingpank, et al.
Annals of Surgical Oncology|July 13, 2016
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell CarcinoidsMichal Radomski, Reetesh K Pai, Yongli Shuai, et al.
Annals of Surgical Oncology|December 15, 2007
Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer centerNiraj J Gusani, Sung W Cho, Christos Colovos, et al.
Annals of Surgical Oncology|October 12, 2017
Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemoperfusionSam Pakraftar, Lekshmi Ramalingam, Yongli Shuai, et al.
Annals of Surgical Oncology|January 6, 2022
Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and ConsequencesCaroline J Rieser, Jurgis Alvikas, Heather Phelos, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Annals of Surgical Oncology|October 11, 2018
Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal MalignanciesM Haroon A Choudry, Yongli Shuai, Heather L Jones, et al.
The Journal of Surgical Research|January 5, 2025
Patient Perspectives of Fertility Following Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: An Opportunity for Improved Perioperative CounselingCameron Schlegel, Amy R Copeland, Michelle Liebdzinski, et al.
Annals of Surgical Oncology|March 3, 2019
Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal MetastasesHaroon A Choudry, Filip Bednar, Yongli Shuai, et al.
Annals of Surgery|October 31, 2013
Outcome analysis of a decade-long experience of isolated hepatic perfusion for unresectable liver metastases at a single institutionDeepa Magge, Haroon A Choudry, Herbert J Zeh, et al.
Journal of Surgical Oncology|January 19, 2016
Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapyTimothy D Lyon, Robert M Turner Ii, Tara N Nikonow, et al.
Journal of Surgical Oncology|February 7, 2013
Aggressive locoregional management of recurrent peritoneal sarcomatosisJoel M Baumgartner, Steven A Ahrendt, James F Pingpank, et al.
Annals of Surgical Oncology|July 13, 2016
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell CarcinoidsMichal Radomski, Reetesh K Pai, Yongli Shuai, et al.
Annals of Surgical Oncology|December 15, 2007
Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer centerNiraj J Gusani, Sung W Cho, Christos Colovos, et al.
Annals of Surgical Oncology|October 12, 2017
Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemoperfusionSam Pakraftar, Lekshmi Ramalingam, Yongli Shuai, et al.
Annals of Surgical Oncology|January 6, 2022
Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and ConsequencesCaroline J Rieser, Jurgis Alvikas, Heather Phelos, et al.
Pageof 6